Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Sashwati Roy
Personal Information
Title
Professor
Expertise
Wound Healing
Institution
Indiana University - Indianapolis
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
0
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
Biofilm-modified macrophage (BAM) phenotype and function in diabetic wounds
About 85% of lower-limb amputations in patients with diabetes are preceded by infected foot ulceration. Emerging studies highlight the significant risk that biofilm infection poses to the non-healing diabetic ulcers. Macrophages (Mphi) are highly plastic innate immune cells that play a central role in tissue repair. These cells of innate immune system serve as the primary defenders against infection. Bacterial pathogens have evolved multiple strategies to evade and subvert host immune system. Emerging studies indicate a role of methicillin-resistant SA (MRSA) biofilms in evading Mphi bacterial effector mechanisms by transforming Mphi towards an alternatively activated M2 phenotype. Strategies of modifying activation state of Mphi have been suggested to be effective in developing anti-biofilm therapeutics. A thorough characterization and phenotyping of chronic wound biofilm modified Mphi (BAMs) is warranted. We seek to understand how does the diabetic wound environment influences BAM phenotype and function. A fine balance between ECM synthesis and degradation is essential to achieve optimal repair. An imbalance in either direction may result in scarring or poor healing outcomes. M2 Mphi may exist as ECM promoting (ECM-promote) vs ECM degrading (ECM-degrade) subpopulations. Striking preliminary data using a preclinical burn biofilm model demonstrated that wounds infected with biofilm overproducing stain of SA rexB- mutant resulted in a massive loss of collagen in the healing granulation tissue compared to the low biofilm producing SA SarA- mutant strain. To be able to pharmacologically stimulate the right kind of behavior in wound ECM turnover, a thorough characterization of ECM-promote vs ECM-degrade mphi is necessary, as well as an understanding of the signals they require for ECM turnover. The following two specific aims will be addressed: AIM 1. Determine if functionally active wmphi isolated from biofilm-infected diabetic wounds show ECM-degrade phenotype causing wound collagen degradation. AIM 2. Investigate whether increased presence of ECM-degrade wound mphi phenotypes in biofilm-infected human diabetic wounds are associated with educed wound collagen levels and increased wound recurrence.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Biofilm-modified macrophage (BAM) phenotype and function in diabetic wounds (Roy, Sashwati)
7/23/2018
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Options
No records to display.
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Wound Healing
The DiaComp Wound Healing Committee has the principal function of furthering the mission of the consortium with regard to diabetic wound healing.
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!